Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Nasdaq Covered Call ETFs for Growth & Income
Nasdaq Covered Call ETFs for Growth & Income

Investors seeking higher income have been flocking to ETFs that use options to generate attractive dividends. There has been a recent surge in new products as providers develop innovative ways to

Will Top-Line Improvement Benefit Palantir in Q2 Earnings?
Will Top-Line Improvement Benefit Palantir in Q2 Earnings?

Palantir Technologies Inc. PLTR will report its second-quarter 2025  results on Aug. 4, after the bell.

We expect a significant year-over-year improvement in the company’s top line in the

NPK Q2 Earnings Down Y/Y As Tariffs Weigh, Sales up 42%
NPK Q2 Earnings Down Y/Y As Tariffs Weigh, Sales up 42%

Shares of National Presto Industries, Inc. NPK have declined 7.1% since the company reported its second quarter earnings for the period ended June 29, 2025. Over the same time frame, the S&P 500

FICO Q3 Earnings Beat Estimates, Strong Scores Drive Up Sales Y/Y
FICO Q3 Earnings Beat Estimates, Strong Scores Drive Up Sales Y/Y

Fair Isaac FICO reported third-quarter fiscal 2025 non-GAAP earnings of $8.57 per share, which surpassed the Zacks Consensus Estimate by 10.87% and jumped 37.1% year over year.Revenues of $536.4

Will PepsiCo's Focus on Premium Drinks Drive the Next Leg of Growth?
Will PepsiCo's Focus on Premium Drinks Drive the Next Leg of Growth?

PepsiCo, Inc. PEP is sharpening its competitive edge in the beverage category by doubling down on premium and functional drinks, aiming to ride the wave of evolving consumer preferences. As demand

PYPL Stock Falls 10% Post Q2 Earnings: Should You Buy, Hold or Fold?
PYPL Stock Falls 10% Post Q2 Earnings: Should You Buy, Hold or Fold?

PayPal Holdings PYPL is no stranger to market volatility, but the more than 10% post-earnings selloff following its second-quarter 2025 results caught many investors off guard. After delivering an

GKOS Stock Falls Despite Q2 Earnings & Revenues Beat, Guidance Raised
GKOS Stock Falls Despite Q2 Earnings & Revenues Beat, Guidance Raised

Glaukos Corporation GKOS reported second-quarter 2025 adjusted loss of 24 cents per share, which was narrower than the Zacks Consensus Estimate of a loss of 26 cents. The figure also improved from

CONMED Q2 Earnings & Revenues Beat Estimates, 2025 Outlook Raised
CONMED Q2 Earnings & Revenues Beat Estimates, 2025 Outlook Raised

CONMED Corporation CNMD delivered second-quarter 2025 adjusted earnings per share (EPS) of $1.15, which beat the Zacks Consensus Estimate of $1.13 by 1.8%. The bottom line improved 17.3% from the

Quanta Tops Q2 Earnings & Revenue Estimates, Lifts 2025 View
Quanta Tops Q2 Earnings & Revenue Estimates, Lifts 2025 View

Quanta Services, Inc. PWR posted a robust second-quarter 2025 performance, highlighted by double-digit revenue growth, margin expansion, and strategic capital deployment. The results reflect strong

AbbVie Stock Eyes Breakout as Pipeline and Profits Grow
AbbVie Stock Eyes Breakout as Pipeline and Profits Grow

AbbVie Inc. (NYSE: ABBV) stock is up nearly 2% in midday trading after delivering a beat-and-raise in its second-quarter 2025 earnings report. The biopharmaceutical giant reported global net

3 Business Services Stocks to Watch in a Prospering Industry
3 Business Services Stocks to Watch in a Prospering Industry
Economic strength, encouraging service activities, and increased adoption and success of the work-from-home trend enable the Zacks Business - Services industry players to support the demand
C.H. Robinson Q2 Earnings Surpass Estimates, Increase Year Over Year
C.H. Robinson Q2 Earnings Surpass Estimates, Increase Year Over Year

C.H. Robinson Worldwide, Inc. (CHRW) reported mixed second-quarter 2025 results, wherein earnings surpassed the Zacks Consensus Estimate while revenues missed the same.

Quarterly earnings per share

Gencor Stock Gains Following Q2 Earnings Amid Revenue Decline
Gencor Stock Gains Following Q2 Earnings Amid Revenue Decline

Shares of Gencor Industries, Inc. GENC have gained 4.1% since the company reported its earnings for the quarter ended March 31, 2025. This compares to the S&P 500 Index’s 0.1% gain over the same

Cigna Q2 Earnings Beat Estimates on Higher Specialty Volumes
Cigna Q2 Earnings Beat Estimates on Higher Specialty Volumes

The Cigna Group CI reported second-quarter 2025 adjusted earnings per share (EPS) of $7.20, which beat the Zacks Consensus Estimate by 0.8%. The bottom line advanced 7.1% year over year. 

Adjusted

Merit Medical Q2 Earnings Beat Estimates, Gross Margin Expands
Merit Medical Q2 Earnings Beat Estimates, Gross Margin Expands

Merit Medical Systems, Inc. MMSI reported second-quarter 2025 adjusted earnings per share (EPS) of $1.01, up 9.8% from the year-ago quarter. The bottom line surpassed the Zacks Consensus Estimate by

Can Phosphate Binders Drive DaVita Stock Before Q2 Earnings?
Can Phosphate Binders Drive DaVita Stock Before Q2 Earnings?

DaVita Inc. DVA is scheduled to report second-quarter 2025 results on Aug. 5, after the closing bell.

In the last reported quarter, the company’s earnings per share (EPS) of $2.00 beat the Zacks

Hims & Hers Leads the Charge in AI-Powered Personalized Healthcare
Hims & Hers Leads the Charge in AI-Powered Personalized Healthcare

The renowned health and wellness platform, Hims & Hers Health, Inc. HIMS, is building a next-generation, digital-first healthcare platform centered around personalization, accessibility and

Clearway Energy to Report Q2 Earnings: What's in Store for the Stock?
Clearway Energy to Report Q2 Earnings: What's in Store for the Stock?

Clearway Energy Inc. CWEN is scheduled to release second-quarter 2025 results on Aug. 5. The company delivered an earnings surprise of 112% in the last reported quarter. Let us discuss the factors

BioCryst Pharmaceuticals Before Q2 Earnings: How to Play the Stock
BioCryst Pharmaceuticals Before Q2 Earnings: How to Play the Stock

BioCryst Pharmaceuticals BCRX is slated to report its second-quarter 2025 results on Aug. 4, before the opening bell. The Zacks Consensus Estimate for quarterly revenues in the to-be-reported

Evercore Stock Gains 2.6% as Q2 Earnings & Revenues Beat Estimates
Evercore Stock Gains 2.6% as Q2 Earnings & Revenues Beat Estimates

Shares of Evercore Inc. EVR gained 2.6% in yesterday’s trading session in response to the announcement of better-than-expected second-quarter 2025 performance. The company’s adjusted earnings per

Cognizant Q2 Earnings Beat Estimates: Will Raised View Aid Shares?
Cognizant Q2 Earnings Beat Estimates: Will Raised View Aid Shares?

Cognizant Technology Solutions CTSH reported non-GAAP earnings of $1.31 per share in the second quarter of 2025, which beat the Zacks Consensus Estimate by 3.97% and increased 12% year over year

Ventas Q2 FFO and Revenues Top Estimates, Same-Store Cash NOI Rises
Ventas Q2 FFO and Revenues Top Estimates, Same-Store Cash NOI Rises

Ventas, Inc. VTR reported second-quarter 2025 normalized funds from operations (FFO) per share of 87 cents, beating the Zacks Consensus Estimate of 85 cents. The reported figure increased 9% from

EverQuote Set to Report Q2 Earnings: What's in the Cards?
EverQuote Set to Report Q2 Earnings: What's in the Cards?

EverQuote, Inc. EVER is expected to register an improvement in its top and bottom lines when it reports second-quarter 2025 results on Aug. 4, after the closing bell.The Zacks Consensus Estimate for

Vertiv Q2 Earnings Beat Estimates, Net Sales Up Y/Y, Shares Rise
Vertiv Q2 Earnings Beat Estimates, Net Sales Up Y/Y, Shares Rise

Vertiv Holdings VRT reported second-quarter 2025 non-GAAP earnings of 95 cents per share, beating the Zacks Consensus Estimate by 14.46%. The figure jumped 41.8% year over year.Net sales increased

Comcast's Q2 Earnings Surpass Estimates, Revenues Increase Y/Y
Comcast's Q2 Earnings Surpass Estimates, Revenues Increase Y/Y

Comcast CMCSA reported second-quarter 2025 adjusted earnings of $1.25 per share, which beat the Zacks Consensus Estimate by 6.84% and increased 3.3% year over year.Consolidated revenues increased